1<html> 2<head> 3 4 5<title>Monoamine oxidase inhibitors: clinical applications</title>
vendor: 63 bytes, line 5
5<script async src="https://www.googletagmanager.com/gtag/js?id=
5G-1MVBX8ZRJ9
vendor: 11 bytes, line 5
5"></script>
5<script>window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);}gtag('js', new Date());gtag('config', 'G-1MVBX8ZRJ9', {'linker': {'accept_incoming': true}});</script>
5</head><body bgcolor="#ffffff" text="#000000" vlink="#293A8B" 6link="#8897DB" alink="#cc0000"> 7<font face="Verdana", "Arial", "Helvetica" font size=-1> 8<blockquote> <blockquote> 9<h3><center> 10<big>Clinical applications of MAO-inhibitors</big> <br> 11<small>by<br> 12Riederer P, Lachenmayer L, Laux G.<br> 13 14Clinical Neurochemistry, <bR>Dept. Psychiatry, Univ. Wuerzburg, <br>Wuerzburg, Germany.<bR> [email protected] 15 16<br> 17 18 <I> Curr Med Chem</I>. 2004 Aug;11(15):2033-43.</small><br><br> 19ABSTRACT</center></h3><blockquote> 20<big><big>M</big></big>onoamine oxidase inhibitors (MAO-I) have been useful in the treatment of both psychiatric and neurological disorders over centuries. Here we focus on the development of this drug treatment. Focus is given on the use of irreversible MAO-I's as well as on reversible ones. Benefit and side effects are reported for Parkinson's disease, Alzheimer's dementia, depression syndrome and panic disorders. The preclinical and clinical effects of selegiline with regard to neuroprotection are highlightened and the conclusion is drawn that there is good evidence for a clinical neuroprotective capacity based on the assumption that the 50 percent recovery of MAO-B is obtained already after a 10 days withdrawal of selegiline. There is also a focus on selegiline's metabolism to amphetamine and metamphetamine. In order to avoid any such effects of metabolic compounds on the cardiovascular system Zydis Selegiline, a melt-tablet avoid of major metabolism to amphetamine and metamphetamine is described in detail. Developments in MAO-I research are discussed in detail as there are moclobemide, lazabemide, rasagiline. Interactions of MAO-I' with tricyclics and serotonin selective reuptake inhibitors (SSRI's) are described as there is mentioning of interactions of MAO-I's with other compounds in general. Tables and figures report on clinical studies and on pharmacological properties of MAO-I's.</blockquote> 21<strong> 22 23 24<P> 25<br> 26<a href=mao-b.html>MAO-B</A><BR> 27<a href=review.html>Rasagiline</a><br> 28<a href=parkinsons-neuroprotection.html>Neuroprotection</A><BR> 29<a href=mao-ab.html>MAO types A and B</A><BR> 30<a href=pd-maoib.html>MAO-B inhibitors/PD</A><BR> 31 32<a href=mechanisms.html>Molecular mechanisms</A><BR> 33<a href=monoamines.html>Rasagiline pharmacology</A><BR> 34<a href=prosurvival.html>Induction of pro-survival genes</A><BR> 35<a href=mitochondria.html>Rasagiline and the mitochondria</><BR> 36<a href=antioxidants.html>Antioxidant strategies against aging</A><BR> 37 38 39<a href=mao-ge.html>MAO research and genetic engineering</A><br> 40 41<a href=rasagiline-parkinsons.html>Rasagiline (Agilect, Azilect) for Parkinson's disease</A><BR><P> 42<strong><center><center> 43 44<br> 45 46<center> 47<a href=refs/index.html>Refs</a><br></b> 48</strong></strong>and further reading<P><b><b> 49<a href=index.html>HOME</a><br> 50<a href="https://www.hedweb.com/confile.htm">HedWeb</a><br> 51 52<a href="https://www.nootropic.com/">Nootropics</A><BR> 53<a href="https://www.cocaine.wiki/">cocaine.wiki</a><br> 54 55<a href="https://www.opioids.wiki/">Future Opioids</a><br> 56<a href="https://www.bltc.com/">BLTC Research</a><br> 57 58<a href="https://www.mdma.net/">MDMA/Ecstasy</A><BR> 59<a href="https://www.superhappiness.com/">Superhapiness?</A><br> 60<a href="https://www.general-anaesthesia.com/">Utopian Surgery?</A><BR> 61<a href="https://www.abolitionist.com/">The Abolitionist Project</A><BR> 62 63<a href="https://www.hedweb.com/hedab.htm">The Hedonistic Imperative</a><br> 64<a href="https://www.reproductive-revolution.com/">The Reproductive Revolution</A><BR> 65<a href="https://www.huxley.net/">Critique of Huxley's <I>Brave New World</I></A><BR><p><strong> 66<a href="https://www.biopsychiatry.com/"><img src=../swan.jpg width=100 height=92 border=0 alt="The Good Drug Guide"></a><br> 67 68<a href="https://www.biopsychiatry.com/">The Good Drug Guide</a></b><br></strong></b> The Responsible Parent's Guide <br>To Healthy Mood Boosters For All The Family<br> 69</center></blockquote></blockquote></font> 70
Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.